Evaluation of miR-130 family members as circulating biomarkers for the diagnosis of bladder cancer.

Jingyao WangLiwen ZhaoXiqi PengKaihao LiuChunduo ZhangXuan ChenYanni HanYongqing Lai

Published in: Journal of clinical laboratory analysis (2020)

The expression levels of miR-130 family members in serum can effectively distinguish the bladder cancer patients from healthy controls. This finding will facilitate the clinical diagnosis of bladder cancer.

Keyphrases

long non coding rna
cell proliferation
end stage renal disease
poor prognosis
long noncoding rna
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes
binding protein
patient reported